Impact of Obstructive Sleep Apnea (OSA) Treatment on Blood Pressure Control in Chronic Kidney Disease

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

Also called NCT05846490

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05846490
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Brazil (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05846490. Randomized; no masking; primary purpose treatment. Start 2024-01-08 (actual); primary completion 2025-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Impact of Obstructive Sleep Apnea (OSA) Treatment on Blood Pressure Control in Chronic Kidney Disease
Condition
Sleep Apnea
Condition
Chronic Kidney Diseases
Intervention (Device)
CPAP
Intervention (Drug)
Usual care
Lead sponsor
University of Sao Paulo (class: other)

Record details

Record id
cardio:ct-nct05846490
Content hash
e1f946d7bd8cdd91ceee01be889b1f9fe357c759c3e35d3be8c3008d9dd2fb66